Audio CD
National Pharma Audioconference: Operating in an Uncertain Environment: The Impact of FDA's Draft Guidance on Medical Journal Reprints and Other Recent Developments
Tuesday, June 17, 2008
|
2008 International Pharma Congress
|
2008 International Device Congress
|
2008 Device Congress CD-ROM
|
Audio CD
National Pharma Audioconference: Lessons from Merck's $671 Million Medicaid Drug Pricing Settlement
Wednesday, March 26, 2008
|
Audio CD
National Pharma Audioconference: Lessons of BMS' $515 Million Settlement for Off-label Promotion, Kickbacks and Drug Pricing
Monday, November 26, 2007
|
Audio CD
National Pharma Audioconference: The InterMune Off-label Settlement and the Rise of Deferred Prosecution Agreements
Wednesday, December 13, 2006
|
Audio CD
National Pharma Audioconference: How the Democratic Takeover of Congress will Impact Pharma
Wednesday, November 29, 2006
|
2007 Pharma Congress CD-ROM
|
2007 FDA Symposium CD-ROM
|
2007 International Pharma Congress
|
2007 Device Congress CD-ROM
|
2006 Pharma Congress CD-ROM
|
2006 Medicaid Congress on CD-ROM
|
Audio CD
National Medicaid Audioconference: How States and Pharmacies are Managing the Transition of Dual Eligibles to Medicare Part D
Wednesday, March 29, 2006
|
Audio CD
National Pharma Audioconference: Compliance in a Highly Litigious World - Creating Good Documents and Avoiding Bad Ones
Wednesday, March 8, 2006
|
Audio CD
National Medicare Audioconference: Innovative State Based Health Information Exchange Programs
Wednesday, February 22, 2006
|
2005 Pharma Congress on CD-ROM
|
2005 Medicare Congress on CD-ROM
|
Audio CD
National Pharma/Medical Device Audioconference: Understanding the Inner Workings of FDA: - A Conversation With Peter Barton Hutt
|
Audio CD
National Medicare Audioconference: Perspectives on Part D Enrollment Indicators and the Impact on Premiums and Beneficiaries
Wednesday, October 19, 2005
|
Audio CD
National Medicare Audioconference: Medicare Promotion of Health Information Systems
Tuesday, September 27, 2005
|
Audio CD
National Pharma Audioconference: Overview and Implications of PhRMA's DTC Drug Marketing Guidelines
Tuesday, September 13, 2005
|
Audio CD
National Pharma Audioconference: Pharmaceutical Drug Pricing and Reporting Issues
Thursday, July 28, 2005
|
Audio CD
National Medicare Audioconference: Impact of the MMA on Dual Eligible Beneficiaries and State Medicaid Programs
Tuesday, June 28, 2005
|
Audio CD
National Pharma Audioconference: Fraud and Abuse Issues for Medical Device Companies
Wednesday, June 8, 2005
|
Audio CD
National Pharma Audioconference: The New California State Law and Other State Laws Targeting Pharmaceutical Sales and Marketing
Monday, May 2, 2005
|
Audio CD
National Pharma Audioconference: FDA's Final Risk Management Guidance: Improving Drug Safety Through RiskMAPs (Risk Minimization Action Plans)
Monday, April 11, 2005
|
Audio CD
National Pharma Audioconference: Update on the Medicare Drug Benefit and Medicare Advantage Regulations
Thursday, February 17, 2005
|
Audio CD
National Pharma Audioconference: The Expanding Scope of Fraud Investigations and Enforcement in Clinical Trials, Publication and Off Label Use
October 26, 2004
|
Audio CD
National Pharma Audioconference: Lessons of the Pfizer Settlement for Off Label Promotion - Compliance Issues and Practices
June 23, 2004
|
Audio CD
National Pharma Audioconference: The Lessons of the Medco Settlement and Implications for PBM Regulation, Roles and Operations
May 11, 2004
|
CD-ROM
2004 eHealth Initiative - Accelerating the Adoption of Electronic Prescribing in the Ambulatory Environment
April 14, 2004
|
Audio CD
National Pharma Audioconference: Analysis of the FDA's Draft Guidance on Direct to Consumer (DTC) Advertising
March 23, 2004
|
Audio CD
National Pharma Audioconference: PBM Regulation, Investigation, Prosecution and Compliance
February 10, 2004
|
Audio CD
National Pharma Audioconference: The New Medicare-Endorsed Prescription Drug Discount Card Program: How it Will Work and Who Will Participate
January 28, 2004
|
Audio CD
National Pharma Audioconference: The Implications of the New Medicare Drug Legislation for Pharmaceutical Manufacturers, PBMs and Health Plans
January 14, 2004
|
Video CD-ROM
The Fourth Annual Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum
November 12-14, 2003
|
Audio CD
National Pharma Audioconference:
Internal Investigations in a Post Sarbanes Oxley World
October 16, 2003
|
Audio CD
National Pharma Audioconference:
Off Label Promotion - Compliance Issues and Practices
October 2, 2003
|
Audio CD
National Pharma Audioconference: Operationalizing the OIG Pharmaceutical Guidance - Grants, Consulting Agreements and Sales and Marketing
September 18, 2003
|
Video CD-ROM
PharmaCongress Spring 2003: HHS OIG Compliance Guidance for the Pharmaceutical Industry: Key Insights from Regulators and Compliance Experts
June 8-9, 2003
|
Audio CD
National Pharma Audioconference: An Analysis of the New OIG Model Compliance Guidance for the Pharmaceutical Industry
May 21, 2003
|
Audio CD
National Pharma Audioconference: An Analysis of the New OIG Model Compliance Guidance for the Pharmaceutical Industry
October 22, 2002
|
Audio CD
National Pharma Audioconference: The Implications of New Corporate Governance Rules on Compliance in the Pharmaceutical Industry
October 8, 2002
|
Audio CD
National Pharma Audioconference: HIPAA for Pharmaceutical Manufacturers, PBMs, and Pharmacies
May 29, 2002
|
